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The Effect of Using Combinations of Commonly Used
Antibiotics in Sudan on Resistant Gram Negative Bacterial
Isolates
S.M. Sulieman
University of Medical Sciences & Technology, Khartoum,
Sudan
Background: Multidrug-resistant Gram-negative bacteria
pose a problem that infection control practitioners, hospi-
tal epidemiologists, clinicians, and hospital administrators
are struggling to control. Failure of treatments (or failure
of medical management of infections) with single antibi-
otics which are commonly used in Sudan is associated with
dramatic increases in the Minimum Inhibitory Concentration
(MIC).
Achieving effective combinations of the commonly used
antibiotics may kill resistant mutants, potentiating suc-
cessful therapy. Theoretically and indeed in practice the
Minimum Inhibitory Concentrations (MICs) of antibiotics can
be reduced if combined with a second antibiotic acting syn-
ergistically or additively.
Methods: Ten clinical drug resistant Gram negative bac-
terial isolates were selected for this study. They belong to
four genera namely, Escherichia, Klebsiella, Pseudomonas
and Enterobacter. A sensitive strain of Pasteurella multo-
cida was selected for comparison. The eleven isolates were
identiﬁed using normal biochemical reactions and were con-
ﬁrmed using API 20E kits.
The MIC’s for the isolates were determined for nine
antibiotics alone (singly), and in the presence of a sec-
ond one. They were amoxicillin, ampicillin, cephalexin,
ciproﬂoxacin, cloxacillin, erythromycin, sulphamethoxa-
zole, tetracycline and trimethoprim. Different concentra-
tions of MIC, 0.5 X MIC, 1 X MIC and 2 X MIC along
time was used to determine the effect of concentra-
tion and time on the isolates. The combinations studied
were:-
(i)Ampicillin with ciproﬂoxacin, (ii)ampicillin with amoxi-
cillin, (iii)ampicillin with cloxacillin, (iv)sulphamethaxazole
with trimethoprim, (v)cephalexin with ciproﬂoxacin,
(vi)cephalexin with amoxicillin, (vii)tetracycline with
erythromycin, (viii)tetracycline with amoxicillin,
(ix)tetracycline with sulphamethoxazole, (x)tetracycline
with ciproﬂoxacin and (xi)tetracycline with trimethoprim.
Results: Eight strains were found to have high MICs.
Pseudomonas aeruginosa and Pasteurella multocida were
sensitive to ciproﬂoxacin while the latter was sensitive to
cloxacillin and erythromycin as well. Using different con-
centrations of MIC, 0.5 X MIC, 1 X MIC and 2 X MIC along time
indicated that resistance to ciproﬂoxacin might not be a fre-
quent occurrence if adequate multiples of the MIC for the
infecting organism were obtained in serum and tissue. How-
ever, using sub-inhibitory concentrations of ciproﬂoxacin
against Klebsiella sp. and Pseudomonas aeruginosa may
lead to emergence of resistant strains. Trimethoprim along
time has a bacteriostatic effect on strains of E. coli,
Klebsiella pneumoniae and Enterobacter. Tetracycline had
bacteriostatic effect at low concentrations and bacterio-
cidal effect at high concentrations against some strains of
E. coli and Pasteurella multocida, while erythromycin was
always bacteriostatic against Klebsiella pneumoniae and did
not change to bacteriocidal at high concentrations.
For some strains, the MICs of certain antibiotics were
successfully reduced in the presence of another antibi-
otic. Eleven combinations were studied. As expected, some
antibiotics caused no reduction in the MIC, as they were not
active against the organisms.
The combination of erythromycin and tetracycline was
synergistic and had bacteriocidal effect against some strains
of E. coli, Enterobacter, Pseudomonas aeruginosa and Pas-
teurella multocida. A combination of tetracycline and
ciproﬂoxacin was synergistic and has bacteriostatic effect
on Klebsiella pneumoniae and Enterobacter. Using ampi-
cillin in combination with ciproﬂoxacin against Klebsiella
pneumoniae and Pseudomonas aeruginosa had synergis-
tic as well as bacteriocidal effect on both isolates.
Using cephalexin in combination with ciproﬂoxacin against
Klebsiella pneumoniae had synergistic and bacterioci-
dal effect. Sulphamethoxazole with trimethoprim had
synergistic and bacteriostatic effect on Pseudomonas aerug-
inosa. A combination of the two penicillins ampicillin and
amoxicillin showed bacteriocidal and synergistic effects
against Klebsiella pneumoniae along time. Tetracycline and
trimethoprim combination was antagonistic against Kleb-
siella pneumoniae and Pseudomonas aeruginosa.
Conclusion: It is recommended that every combination of
antibiotics should be tested in vitro with regard to its action
characteristics, to avoid undesirable effects of combina-
tions. Practical clinical experiences are needed to decide
on possible clinical beneﬁts of using any two antibiotics
in combination. Requests for testing combinations could,
therefore, be directed at excluding antagonistic effects
between two antimicrobial agents.
doi:10.1016/j.ijid.2008.05.305
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First Report of blaCTX-M Type Extended-Spectrum-Beta-
Lactamases in an Academic Hospital in Bloemfontein,
South Africa
A. Van der Spoel van Dijk ∗, S. Moshoeshoe
University of the Free State, Bloemfontein, South Africa
Background: Klebsiella pneumoniae is an important
organisms causing nosocomial infections in hospitals and in
recent years an increase in reports on plasmid-mediated
extended-spectrum-beta-lactamases (ESBLs) of the CTX-M-
type is noticed. ESBLs are ˇ-lactamase enzymes which
hydrolyse oxyimino cephalosporins and are inhibited ˇ-
lactamase inhibitors such as clavulanic acid or tazobactam.
CTX-M-type ESBLs in K. pneumoniae in South Africa was
ﬁrst reported in 2003, but recent studies found no blaCTX-
M genes amongst isolated from a hospital in Pretoria. The
aim of this study was to examine the presence of blaCTX-M
genes in ESBL producing K.pneumoniae isolates from speci-
mens from patients in an academic hospital in Bloemfontein,
South Africa.
Method: Thirty six K. pneumoniae isolated were col-
lected, six from neonates during an outbreak in 2004 and
30 from patients from the Universitas Academic Hospital,
Bloemfontein from during 2006. ESBL strains were distin-
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guished by antibiograms using the Microscan method to
determine elevated levels of ceftazidime, cefotaxime and
aztreonam. Isolates were examined for the presence of a
gene coding for the four CTX-M ESBL-enzyme groups by
ampliﬁcation with speciﬁc primers for the different groups
and for the blaSHV SHV-gene speciﬁc primers. Bidirectional
sequencing was done for genes ampliﬁed to determine
strains differences.
Results: The 30 form 2006 gave ceftazidime and cefo-
taxime MIC ratios >16 and 32mg/ml respectively, implying
production of ESBLs. DNA ampliﬁcation identiﬁed genes of
the blaSHV type in the isolates from the neonates and both
blaCTX-M1 and blaSHV types in the other isolates. The preva-
lences of CTX-M1-type, SHV-type and a dual carriage was
14%, 46% and 14% respectively. Sequencing further identi-
ﬁed several subtypes including SHV-1, -2, -2a, 5, -5a -12,
and -31 enzymes and three CTX-M1 types (CTX-3, -15 and
-22). It is possible that the remaining isolates may have the
blaTEM type gene that was not expected and therefore not
tested.
Conclusion: The relatively high numbers of K. pneu-
moniae harbouring the CTX-M-type ESBLs enzymes in the
Bloemfontein hospital isolates is alarming and further inves-
tigations into the extent of the problem needs urgent
attention.
doi:10.1016/j.ijid.2008.05.306
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Background: Salmonella enterica serovars are among the
most important agents of food-borne infections through-
out the world. Serovars Typhimurium and Enteritidis are
the most prevalent non-typhoidal Salmonella in Malaysia.
Strains of Salmonella which are resistant to a range of
antimicrobials, including ﬁrst-choice agents for the treat-
ment of humans, have emerged and are threatening to
become a serious public health problem. The objectives of
the study are to determine the rates of antimicrobial resis-
tance and the genomic diversity of Salmonella Typhimurium
and S. Enteritidis and S. Corvalis.
Methods: 151 strains of Salmonellae including 47 S
Typhimurium (14 clinical and 33 zoonotic), 90 SEnteritidis
(32 clinical and 59 zoonotic) and 13 S. Corvalis (clinical),
were tested with 15 different antibiotic discs. PCR was
applied to detect the resistance genes and PFGE was used
to determine the genomic differentiation of the Salmonel-
lae.
Results: Overall, 25% of strains were multi-drug resis-
tant (resist to more than 3 antibiotics). Resistance towards
cephalosporin antibiotics was also observed: 3% of the iso-
lates were resistant to ceftriaxone and cefotaxime, 3% to
cefuroxime, 18% to cephalothin. Resistant genes (blaTEM,
strA, sul, aad and tet), have been found among the
Salmonella strains and are thought to be responsible for
the emergence of MDR strains. PFGE subtyped Typhimurium,
Enteritidis and Corvalis into 39, 14 and 3 pulsotypes respec-
tively.
Conclusion: An emergence of MDR Salmonella to 3rd
generation of cephalosporin was observed and high hetero-
geneity was found among the serotypes of Typhimurium and
Enteritidis.
doi:10.1016/j.ijid.2008.05.307
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Antibiotic Resistance Patterns and Genotypes of Heli-
cobacter pylori Isolated from Ethinically Different
Dyspeptic Patients in Kuala Lumpur Malaysia
H. Salasawati ∗, M. Ramelah
HUKM, Bandar Tun Razak, Malaysia
Background: Data on Helicobacter pylori antibiotic sus-
ceptibilities in Malaysia are limited, despite resistance being
a key factor in treatment failure. The present study deter-
mine antibiotic resistance rates and evaluates vacA alleles,
cagA and cagE status of Helicobacter pylori isolates from
dyspeptic patients in Kuala Lumpur, Malaysia in three ethnic
groups: Malays, Chinese and Indians.
Methods: All patients with cultured positive H. pylori
were recruited prospectively. H. pylori isolates were sub
cultured from biopsies of the gastric antrum obtained from
patients who underwent endoscopy for dyspepsia at the
Hospital UKM. Gastric antral biopsies were subcultured
on blood agar plates which were then incubated under
microaerophilic conditions at 37 ◦C for 5 days. H. pylori
strains were identiﬁed by their colonial morphology, Gram
stain appearance, oxidase and urease positivity. The sus-
ceptibilities of H. pylori isolates were determined by disc
diffusion and epsilometer (E) tests on 188 H. pylori iso-
lates. Deoxyribonucleic acid (DNA) was extracted from the
H. pylori isolates using the commercially available kit. Poly-
merase chain reaction was carried out to determine the
genotypes (vacA alleles, cagA and cagE).
Results: In vitro resistance rates was 24.5% for metron-
idazole. High-level-resistance was a feature of all (100%) of
the metronidazole (MIC>256mg/L) resistant strains. All iso-
lates were susceptible to amoxycillin and clarithromycin.
No associations between resistance and either the gen-
der or ethnic group (Malays, Chinese and Indians) of the
patients were detected. Resistant and susceptible isolates
were genotypically diverse with respect to cagA, cagE. and
vacA type.
Conclusion: This study showed metronidazole-resistance
rate was 24.5% for H. pylori with none of the isolates
resistance to amoxycillin and clarithromycin. Continued
surveillance, particularly of high-level resistance of metron-
idazole (MIC>256mg/L), is recommended to monitor the
effects of the treatment strategy for H. pylori eradication.
Further study is required to correlate these ﬁndings with
clinical response to antimicrobial therapy in patients with
H. pylori infection.
doi:10.1016/j.ijid.2008.05.308
